BIOMAT Database Logo BIOMAT Database Logo

Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis. 1986

K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Institute of Pharmaceutical Science, Hiroshima University School of Medicine, Japan.

Bile acid profiles of bile, urine, and feces obtained from a patient with cerebrotendinous xanthomatosis on the same day have been analyzed by gas-liquid chromatography-mass spectrometry after fractionation into groups by mode of conjugation by an ion-exchange chromatography. The predominant biliary bile acid was cholic acid conjugated with glycine and taurine. Lesser amounts of the amino acid conjugates of chenodeoxycholic acid, ursodeoxycholic acid, 7-ketodeoxycholic acid, allocholic acid, and deoxycholic acid, and of unconjugated norcholic acid and allonorcholic acid were also present in the bile. The major fecal bile acid was 7-epicholic acid. Relatively large amounts of bile acids were excreted in the urine. Unconjugated 7-epicholic acid, norcholic acid, allonorcholic acid, and cholic acid predominated. The bile acid profiles of the patient were different from those of normal subjects and should be useful for the diagnosis.

UI MeSH Term Description Entries
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D013710 Tendons Fibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures. Endotenon,Epotenon,Tendons, Para-Articular,Tendons, Paraarticular,Endotenons,Epotenons,Para-Articular Tendon,Para-Articular Tendons,Paraarticular Tendon,Paraarticular Tendons,Tendon,Tendon, Para-Articular,Tendon, Paraarticular,Tendons, Para Articular
D014973 Xanthomatosis A condition marked by the development of widespread xanthomas, yellow tumor-like structures filled with lipid deposits. Xanthomas can be found in a variety of tissues including the SKIN; TENDONS; joints of KNEES and ELBOWS. Xanthomatosis is associated with disturbance of LIPID METABOLISM and formation of FOAM CELLS. Xanthoma,Xanthomas,Xanthomatoses

Related Publications

K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Serum bile acid profiles in cerebrotendinous xanthomatosis.
February 1982, Clinica chimica acta; international journal of clinical chemistry,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis.
October 2023, Nutrients,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
[Cerebrotendinous xanthomatosis and bile acids].
July 1984, Nihon rinsho. Japanese journal of clinical medicine,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Identification of short side chain bile acids in urine of patients with cerebrotendinous xanthomatosis.
October 1990, Journal of lipid research,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.
October 1985, Clinica chimica acta; international journal of clinical chemistry,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
November 1980, Journal of lipid research,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
February 1987, Biochimica et biophysica acta,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
October 1985, Annals of neurology,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
August 1987, Journal of lipid research,
K Kihira, and K Shimazu, and M Kuwabara, and M Yoshii, and H Takeuchi, and I Nakano, and S Ozawa, and M Onuki, and Y Hatta, and T Hoshita
Coronary heart disease in a patient with cerebrotendinous xanthomatosis.
June 2004, Journal of internal medicine,
Copied contents to your clipboard!